Oculis Holding AG (OCS) Divestments (2023 - 2026)
Oculis Holding AG (OCS) posted quarterly Divestments of -$32.6 million for Q1 2026, up 43.12% year-over-year from -$22.8 million in Q1 2025, and up 20.15% quarter-over-quarter from -$40.8 million in Q4 2025.
Analysis
Oculis Holding AG (OCS) Divestments (2023 - 2026) Analysis & Trends
Oculis Holding AG's Divestments history runs 4 years deep, the most recent figure standing at -$32.6 million for Q1 2026.
- In Q1 2026, Divestments rose 43.12% year-over-year to -$32.6 million; the TTM figure through Mar 2026 stood at -$45.5 million (up 37.86% YoY), while the FY2025 annual figure was -$73.5 million, down 302.01% from the prior year.
- Divestments for Q1 2026 stood at -$32.6 million, up from -$40.8 million in the prior quarter.
- The five-year high for Divestments was $31.1 million in Q2 2025, with the low at -$57.3 million in Q1 2025.
- The 4-year median for Divestments is -$3.2 million (2025), against an average of -$9.0 million.
- Peak annual rise in Divestments reached 253.72% in 2025, while the deepest fall reached 4280.86% in 2025.
- Oculis Holding AG's Divestments stood at $25.9 million in 2023, then tumbled by 103.6% to -$931481.8 in 2024, then slumped by 4280.86% to -$40.8 million in 2025, then grew by 20.15% to -$32.6 million in 2026.
- Business Quant data shows OCS's Divestments at -$32.6 million in Q1 2026, -$40.8 million in Q4 2025, and -$3.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Oculis Holding AG | 634.75 Mn | 345.87 Mn | - | -10.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.71 Mn |
| Mar 31, 2026 | -32.58 Mn |
| Dec 31, 2025 | -40.81 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Jun 30, 2025 | 31.14 Mn |
| Mar 31, 2025 | -57.29 Mn |
| Dec 31, 2024 | -931,481.83 |
| Sep 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | -20.26 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | 25.86 Mn |
| Sep 30, 2023 | -4.32 Mn |